Finzati - Logo
CBT logo

Cabot Corp.

CBT • Chemicals - Specialty
$81.48
▲ +0.29 (+0.36%)
Current price
EarningsLatest report: Mar 31, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$4.25B
Growth
4.7%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Stable or improving margins · 8.9%Positive free cash flow · 7.28Consistent free cash flow · 4/5Reasonable earnings multiple · 12.34Manageable debt level · 0.78
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 5, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$81.48
Change0.36%
Shares Out52.20M
Market Cap$4.25B
Enterprise Value$5.30B
52W Range58.33 - 93.15
Beta0.83
P/E14.92
P/S1.19
P/B2.71
P/FCF9.27
EV/Sales1.48

Investment DNA

How strong this company looks for long-term investors

79
out of 100
Business Quality
Margins, moat, returns
72/100
Financial Strength
Debt, cash, stability
77/100
Growth Potential
Revenue and expansion
75/100
Price Attractiveness
Cheap or expensive today
89/100
Why this score▼
Stable or improving margins · 8.9%Positive free cash flow · 7.28Consistent free cash flow · 4/5Reasonable earnings multiple · 12.34Manageable debt level · 0.78Healthy liquidity · 1.61

Analyst view

Analyst sentiment and price target

CBT
Analyst sentiment
Based on 15 analyst votes · 2026-09-05
70/100
Bullish
Bullish
7
Hold
7
Bearish
1
Price Target
2026-06-24
Low
$75.00
Mean
$86.00
Median
$85.50
High
$98.00

Company Overview

IPO: 11/5/1980
Industry: Chemicals - Specialty
P/B i: 2.71
Debt / Equity i: 0.78
Operating Margin: 16.73%
Net Margin: 8.91%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.78
Current Ratio: 1.61
Quick Ratio: 1.08
Status: Good

Insider Transactions

Recent executive and insider activity

Masterson William F III
Transaction: 06/12/2026
BUY
Change
—
Price
Not reported
Filing
06/16/2026
Type
BUY
Keohane Sean D
Transaction: 06/12/2026
BUY
Change
—
Price
Not reported
Filing
06/16/2026
Type
BUY
McLaughlin Erica
Transaction: 06/12/2026
BUY
Change
—
Price
Not reported
Filing
06/16/2026
Type
BUY